Stockscreener 앱 받기
39.66
8.93%
-3.89
시간 외 거래:
40.00
0.34
+0.86%
전일 마감가:
$43.55
열려 있는:
$40.72
하루 거래량:
223.88K
Relative Volume:
2.03
시가총액:
$2.01B
수익:
$32.72M
순이익/손실:
$-27.55M
주가수익비율:
-69.36
EPS:
-0.5718
순현금흐름:
$-41.40M
1주 성능:
-5.68%
1개월 성능:
-0.10%
6개월 성능:
+55.83%
1년 성능:
+292.90%
1일 변동 폭
$39.22
$40.86
1주일 범위
$39.22
$45.74
52주 변동 폭
$8.03
$57.14
나노바이오틱스 Stock (NBTX) Company Profile
Compare NBTX vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
39.66 | 2.22B | 32.72M | -27.55M | -41.40M | -0.5718 |
VRTX
Vertex Pharmaceuticals Inc
|
547.59 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
828.50 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,011.11 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.89 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
211.58 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
나노바이오틱스 Stock (NBTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-06 | 개시 | TD Cowen | Buy |
| 2024-08-28 | 개시 | Guggenheim | Buy |
| 2023-12-08 | 개시 | Leerink Partners | Outperform |
| 2021-01-06 | 개시 | Evercore ISI | Outperform |
나노바이오틱스 주식(NBTX)의 최신 뉴스
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap UpHere's What Happened - MarketBeat
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Qatar Investment Authority (NBTX) reports 3.53M Nanobiotix ADRs under sole control - Stock Titan
Nanobiotix (NASDAQ:NBTX) Stock Price Down 5.4%What's Next? - MarketBeat
NBTXNanobiotix ADR Dividends - Finviz
NBTX Stock Price, Quote & Chart - ChartMill
5NRA Forecast — Price Target — Prediction for 2027 - TradingView
NANOBIOTIX Announces Closing of Global Offering - GlobeNewswire Inc.
NANOBIOTIX Announces Closing of Global Offering - Finansavisen
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris - Finansavisen
XP posts downbeat Q1 earnings, joins Akamai Technologies and other big stocks moving lower in Tuesday's pre-market session - MSN
XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's P - Benzinga
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer - ChartMill
Nanobiotix (NASDAQ:NBTX) Hits New 1-Year HighHere's What Happened - MarketBeat
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study - ChartMill
NBTX Forecast, Price Target & Analyst Ratings | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix (NASDAQ:NBTX) Trading 7.2% HigherShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap DownHere's What Happened - MarketBeat
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology - ChartMill
Voting Rights and Shares Capital of the Company - Finansavisen
Nanobiotix H2 Earnings Call Highlights - Yahoo Finance
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - Finansavisen
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
NANOBIOTIX Statement Regarding Recent Media Speculation - ChartMill
El Pollo Loco Posts Upbeat Q4 Results, Joins Kyivstar Group, American Public Education And Other Big Stocks Moving Higher On Friday - Benzinga
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Nanobiotix (NASDAQ:NBTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Sets New 52-Week HighWhat's Next? - MarketBeat
Short Interest in Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Grows By 114.9% - MarketBeat
NANOBIOTIX to Participate in Investor Conferences in March - ChartMill
Semtech Posts Mixed Q3 Results, Joins Zhihu, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Ma - Benzinga
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market - Benzinga
나노바이오틱스 (NBTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.00%
3.22%
자본화:
|
볼륨(24시간):